1.36
-0.07(-4.90%)
Currency In USD
| Previous Close | 1.43 |
| Open | 1.44 |
| Day High | 1.47 |
| Day Low | 1.26 |
| 52-Week High | 376 |
| 52-Week Low | 1.26 |
| Volume | 118,662 |
| Average Volume | 676,863 |
| Market Cap | 4.12M |
| PE | -0.01 |
| EPS | -118.56 |
| Moving Average 50 Days | 2.6 |
| Moving Average 200 Days | 17.49 |
| Change | -0.07 |
If you invested $1000 in CERo Therapeutics Holdings, Inc. (CERO) since IPO date, it would be worth $1.37 as of March 12, 2025 at a share price of $1.36. Whereas If you bought $1000 worth of CERo Therapeutics Holdings, Inc. (CERO) shares 3 years ago, it would be worth $1.36 as of March 12, 2025 at a share price of $1.36.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to Manage Translational Assays
GlobeNewswire Inc.
Mar 06, 2025 1:15 PM GMT
Company continues toward the initiation of its Phase 1 Clinical Trial in AML for CER-1236 SOUTH SAN FRANSCISCO, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative imm
CERo Therapeutics Holdings, Inc. to Present Data at the Society for Immunotherapy of Cancer Spring Scientific March 12-14
GlobeNewswire Inc.
Mar 05, 2025 1:15 PM GMT
New poster to highlight preclinical data of CER-1236 in ovarian cancer SOUTH SAN FRANSCISCO, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company
CERo Therapeutics Holdings, Inc. Highlights Progress
GlobeNewswire Inc.
Feb 06, 2025 1:15 PM GMT
Increased cash balance and momentum with both Nasdaq and Phase 1 trial initiation mark strong beginning for 2025 SOUTH SAN FRANSCISCO, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Compan